Home›Search›Infectious Agents and Cancer

Infectious Agents and Cancer

BioMed Central Ltd · United Kingdom · Est. 1998

ISSN1750-9378eISSN1750-9378

SJR Q2✓ WOS SCIE✓ Scopus / SJR✓ DOAJ✓ Open Access

100

/ 100

High Trust

PubScope credibility score from verifiable indexing & ethics signals

Score Breakdown

◆ WoS flagship (SCIE/SSCI/AHCI)78

✓ Corroboration (4 more)+22

Total100

Level data: Norwegian Register (HK-dir), NLOD 2.0. · Third-party records · how this is calculated · Report an error →

⚡ Speed vs Prestige

How does this journal balance review speed with impact level?

days submission → published

measured · last 20 articles · accept 70d

weeks to publish · journal-reported

Average · vs ~15 wk median

SJR Rank

Top 50% in field

Impact Factor & Quartile · Web of Science (JCR)

✓ Indexed in the Web of Science Core Collection (SCIE) — Clarivate publishes an official Journal Impact Factor and JCR quartile for this journal.

See the official Impact Factor & quartile on the journal’s page ↗

The Impact Factor & JCR quartile are licensed by Clarivate — we link you to the official source instead of reprinting a number that can go out of date. Open metrics below: SCImago Q2. Source: Clarivate Journal Citation Reports.

SJR Scorei

0.92

H-Indexi

CiteScore

View ↗

Scopus metric · on the journal’s page

SNIPi

0.731

Total Worksi

1,290

Total Citationsi

22,998

2yr Mean Citednessi

2.28

Open Impact Factor alternative

Aims & Scope

Infectious Agents and Cancer is an open access journal dedicated to publishing novel insights on the associations between chronic infections and cancer. The journal focuses on basic, clinical, epidemiological and translational research to showcase the latest studies and resources related to cancer prevention, diagnosis, treatment and palliative care, with a particular interest in the innovative field of molecular research in cancer causation. The journal is proudly affiliated with the African Organisation for Research & Training In Cancer and is overseen by an expert international Editorial Board.

General Information

Country / RegionUnited Kingdom

Primary LanguageEnglish

1st Year Published1998

Annual Volume~ 82 articles / year

StatusActive (last: 2026)

Total Publications1,290

Publisher OrgBioMed Central

OA Since2005

Visit Journal Website

Submission Info

Peer ReviewSingle-blind

Review Time~17 weeks

Acceptance Rate—

OA LicenseCC BY, CC BY-NC-ND

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Plagiarism Detection✓ Yes

📦 Long-term Preservation

British Library; Koninklijke BibliotheekCLOCKSSLOCKSSPorticoPMC

Think.Check.Submit Compliance

thinkchecksubmit.org

10/12 · 83%

✅

Do you know the journal / publisher?

BioMed Central Ltd

✅

Does the journal have a website?

✓ Linked

✅

Is the ISSN verified?

1750-9378 / 1750-9378

✅

Indexed in a trusted database?

WoS, Scopus, DOAJ, PubMed

✅

Peer review process documented?

Single-blind

❌

Follows ethical publishing standards (COPE)?

N/A

❌

APC fees clearly disclosed?

N/A

✅

Not on predatory/blacklists?

✓ Clean

✅

Long-term digital preservation?

British Library; Koninklijke Bibliotheek, CLOCKSS, LOCKSS, Portico, PMC

✅

Plagiarism detection in place?

Yes

✅

Listed in DOAJ (verified OA)?

DOAJ verified

✅

Primary language documented?

English

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Citations received

1.5k

2019

1.8k

2020

1.2k

2021

936

2022

804

2023

322

2024

220

2025

2026

Source: OpenAlex · Each year’s green bar = citations earned by that year’s papers, counted to date — so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

EpidemiologyQ2

Infectious DiseasesQ2

OncologyQ2

Cancer ResearchQ3

Subject Classification

Web of Science Categories

ImmunologyOncology

Scopus Categories

Cancer ResearchOncologyInfectious DiseasesEpidemiology

Research Topics (OpenAlex)

Cervical Cancer and HPV ResearchViral-associated cancers and disordersHead and Neck Cancer StudiesLymphoma Diagnosis and TreatmentReproductive tract infections researchHepatitis B Virus StudiesCytomegalovirus and herpesvirus researchEndometrial and Cervical Cancer TreatmentsHepatitis C virus researchWomen's cancer prevention and management

Frequently asked questions about Infectious Agents and Cancer

Is Infectious Agents and Cancer a predatory journal?

PubScope has no integrity flags on record for Infectious Agents and Cancer: it is indexed in Web of Science, Scopus, DOAJ, and is not on DOAJ's withdrawn list. Its PubScope Trust Score is 100/100. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.

What is the impact factor of Infectious Agents and Cancer?

Infectious Agents and Cancer is indexed in the Web of Science Core Collection, so Clarivate publishes an official Journal Impact Factor for it (since the 2023 Journal Citation Reports, every Core Collection journal — including Arts & Humanities and Emerging Sources titles — receives one). PubScope links to Clarivate's official source rather than reprinting the number, which can be out of date. Its open 2-year mean citedness is 2.28.

Is Infectious Agents and Cancer indexed in Scopus and Web of Science?

Infectious Agents and Cancer is indexed in Web of Science, Scopus, DOAJ.